{"id":1176,"date":"2026-05-19T10:06:38","date_gmt":"2026-05-19T10:06:38","guid":{"rendered":"https:\/\/elmoustkbal.com\/?p=1176"},"modified":"2026-05-19T10:06:38","modified_gmt":"2026-05-19T10:06:38","slug":"in-addition-the-effectiveness-of-such-immune-modulation-treatment-in-dmd-will-likely-depend-greatly-upon-the-specific-stage-of-disease-at-which-it-is-launched-and-efforts-to-determine-the","status":"publish","type":"post","link":"https:\/\/elmoustkbal.com\/?p=1176","title":{"rendered":"\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it is launched, and efforts to determine the most appropriate therapeutic window, perhaps guided by non-invasive biomarkers to assess DAMP-mediated activation of the innate immune system, should be pursued in future studies"},"content":{"rendered":"

\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it is launched, and efforts to determine the most appropriate therapeutic window, perhaps guided by non-invasive biomarkers to assess DAMP-mediated activation of the innate immune system, should be pursued in future studies. == Materials and Methods == == Animals == Wild-type (WT; C57BL\/10) and mdx (C57BL\/10ScSn-Dmdmdx\/J) mouse breeding pairs were originally purchased from The Jackson Laboratories (Bar Harbor, ME); mice lacking TLR4 (TLR4\/) were kindly provided by S. toward a more anti-inflammatory (iNOSnegCD206pos) profile. In vitroexperiments confirmed that lack of TLR4 is sufficient to influence macrophage activation status in response to classical polarizing stimuli such as IFN-gamma and IL-4. Finally, treatment of dystrophic mice with glycyrrhizin, an inhibitor from the endogenous TLR4 ligand, large mobility group box (HMGB1), also pointed to involvement of the HMGB1TLR4 axis in promoting dystrophic diaphragm pathology. Taken together, our findings uncover TLR4 and the innate immune system as important players in the pathophysiology of DMD. Accordingly, targeting either TLR4 or its endogenous ligands may provide a new therapeutic strategy to slow disease progression. == Introduction == Duchenne muscular dystrophy (DMD) is the most common X-linked lethal disorder in humans, with an incidence of 1 in 3500 male births. Because the disease involves the diaphragm and other respiratory muscles, most patients will pass away of respiratory failure unless supported by mechanical ventilation. DMD is caused by defects in dystrophin, a protein which confers important structural (e. g. mechanical reinforcement of sarcolemma) and signaling (e. g. regulation of intracellular calcium and nitric oxide synthase) properties to skeletal muscle (1). The G-418 disulfate absence of dystrophin is associated with skeletal muscle fiber death, which occurs principally through necrosis. In DMD patients, corticosteroids are the COPB2<\/a> only pharmacological brokers approved intended for slowing disease progression, albeit with very limited success and considerable side effects (2). The mdx mouse, which harbors a premature termination codon in the dystrophin gene, is the most commonly used creature model of DMD (3). It is clear that dystrophin deficiency is necessary, but not sufficient on its own, to fully take into account the pathophysiology of DMD. In this regard, the critical role played by inflammation continues to be demonstrated by eliminating macrophages and other inflammatory cell types in mdx mice (46), as well as through strategies to inhibit important mediators of inflammation such as NF-kB (7) and TNF- (8). Thus current evidence suggests that the repeated episodes of muscle fiber necrosis as well as the subsequent fibrotic response of DMD skeletal muscle are driven to a large extent by complex interactions between dystrophin deficiency and the host immune response (9). The innate immune system has evolved to identify invading pathogens via a set of germline-encoded receptors, termed pattern acknowledgement receptors (PRRs), which are in a position of realizing structural motifs common to many different microorganisms (10). It is increasingly evident that these PRRs also recognize and respond to various endogenous tissue molecules found in pathological conditions (11, 12). In general, endogenous ligands intended for PRRs are molecules which accumulate in G-418 disulfate non-physiologic sites or amounts or G-418 disulfate<\/a> have been altered from their native state, as a result of tissue damage. They have thus been known as endogenous danger signals, alarmins or damage associated molecular patterns (DAMPs). One of the largest classes of PRRs is the Toll-like receptor (TLR) family members, whose users differ with regard to the microbial components which they detect as well as their subcellular distribution (10). The best analyzed of these is probably Toll-like receptor 4 (TLR4), which is localized to the cell surface where it recognizes bacterial lipopolysaccharide (LPS). The list of non-microbial DAMPs recognized by TLR4 continues to be steadily accumulating in the literature, which includes components of the extracellular matrix, heat shock proteins and other molecules associated with cell death or tissue inflammation (11, 12). Among the DAMPs recognized by TLR4 is large mobility group box 1 (HMGB1), a highly conserved protein that normally performs homeostatic functions in the nucleus (13), but which may be released from cells during cell death through active or passive mechanisms (1317). The therapeutic benefits of inhibiting either TLR4 or its endogenous ligands have been exhibited in disease models including various organs (1821). In this study, we hypothesized that endogenous DAMPs, including but not necessarily limited to HMGB1, could signal through TLR4 to stimulate innate immunity and thereby play a direct role in driving disease progression in the mdx mouse model of DMD. == Results == == TLR4 upregulation and hyperresponsiveness in mdx mice == To ascertain whether exaggerated TLR4 signaling could be involved in DMD pathophysiology, we first assessed TLR4 mRNA expression levels in the diaphragm. As compared with WT mice, an approximate 3-fold increase of TLR4 mRNA was observed in the mdx group (Fig. 1A). We next evaluated whether dystrophic muscles are definitely more responsive to TLR4 stimulationin palpitante, by injecting WT and mdx mice with the exogenous TLR4 agonist LPS (25 mg\/kg i. p. ). Diaphragm muscles were removed 1 . 5 and three or more h later on for western blotting (Fig. 1B) to assess IkB phosphorylation (p-IkB) and total IkB degradation, which were used because an index of NF-kB activation. In response to LPS supervision, the mdx muscles.<\/p>\n","protected":false},"excerpt":{"rendered":"

\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[45],"tags":[],"class_list":["post-1176","post","type-post","status-publish","format-standard","hentry","category-cox"],"yoast_head":"\n\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it is launched, and efforts to determine the most appropriate therapeutic window, perhaps guided by non-invasive biomarkers to assess DAMP-mediated activation of the innate immune system, should be pursued in future studies - DHFR inhibitors in non-small cell lung cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/elmoustkbal.com\/?p=1176\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it is launched, and efforts to determine the most appropriate therapeutic window, perhaps guided by non-invasive biomarkers to assess DAMP-mediated activation of the innate immune system, should be pursued in future studies - DHFR inhibitors in non-small cell lung cancer\" \/>\n<meta property=\"og:description\" content=\"\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/elmoustkbal.com\/?p=1176\" \/>\n<meta property=\"og:site_name\" content=\"DHFR inhibitors in non-small cell lung cancer\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-19T10:06:38+00:00\" \/>\n<meta name=\"author\" content=\"webmaster\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"webmaster\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1176#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1176\"},\"author\":{\"name\":\"webmaster\",\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/#\\\/schema\\\/person\\\/6ba91697c07f5b1e48a1c50fec2fd4a0\"},\"headline\":\"\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it is launched, and efforts to determine the most appropriate therapeutic window, perhaps guided by non-invasive biomarkers to assess DAMP-mediated activation of the innate immune system, should be pursued in future studies\",\"datePublished\":\"2026-05-19T10:06:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1176\"},\"wordCount\":912,\"articleSection\":[\"COX\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1176\",\"url\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1176\",\"name\":\"\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it is launched, and efforts to determine the most appropriate therapeutic window, perhaps guided by non-invasive biomarkers to assess DAMP-mediated activation of the innate immune system, should be pursued in future studies - DHFR inhibitors in non-small cell lung cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/#website\"},\"datePublished\":\"2026-05-19T10:06:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/#\\\/schema\\\/person\\\/6ba91697c07f5b1e48a1c50fec2fd4a0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1176#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/elmoustkbal.com\\\/?p=1176\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/?p=1176#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/elmoustkbal.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it is launched, and efforts to determine the most appropriate therapeutic window, perhaps guided by non-invasive biomarkers to assess DAMP-mediated activation of the innate immune system, should be pursued in future studies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/#website\",\"url\":\"https:\\\/\\\/elmoustkbal.com\\\/\",\"name\":\"DHFR inhibitors in non-small cell lung cancer\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/elmoustkbal.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/elmoustkbal.com\\\/#\\\/schema\\\/person\\\/6ba91697c07f5b1e48a1c50fec2fd4a0\",\"name\":\"webmaster\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/66fbd3a9ef48c403fd533a73978e5557cc8b799f7e461809e4f768dafe87f404?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/66fbd3a9ef48c403fd533a73978e5557cc8b799f7e461809e4f768dafe87f404?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/66fbd3a9ef48c403fd533a73978e5557cc8b799f7e461809e4f768dafe87f404?s=96&d=mm&r=g\",\"caption\":\"webmaster\"},\"sameAs\":[\"http:\\\/\\\/elmoustkbal.com\"],\"url\":\"https:\\\/\\\/elmoustkbal.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it is launched, and efforts to determine the most appropriate therapeutic window, perhaps guided by non-invasive biomarkers to assess DAMP-mediated activation of the innate immune system, should be pursued in future studies - DHFR inhibitors in non-small cell lung cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/elmoustkbal.com\/?p=1176","og_locale":"en_US","og_type":"article","og_title":"\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it is launched, and efforts to determine the most appropriate therapeutic window, perhaps guided by non-invasive biomarkers to assess DAMP-mediated activation of the innate immune system, should be pursued in future studies - DHFR inhibitors in non-small cell lung cancer","og_description":"\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it…","og_url":"https:\/\/elmoustkbal.com\/?p=1176","og_site_name":"DHFR inhibitors in non-small cell lung cancer","article_published_time":"2026-05-19T10:06:38+00:00","author":"webmaster","twitter_card":"summary_large_image","twitter_misc":{"Written by":"webmaster","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/elmoustkbal.com\/?p=1176#article","isPartOf":{"@id":"https:\/\/elmoustkbal.com\/?p=1176"},"author":{"name":"webmaster","@id":"https:\/\/elmoustkbal.com\/#\/schema\/person\/6ba91697c07f5b1e48a1c50fec2fd4a0"},"headline":"\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it is launched, and efforts to determine the most appropriate therapeutic window, perhaps guided by non-invasive biomarkers to assess DAMP-mediated activation of the innate immune system, should be pursued in future studies","datePublished":"2026-05-19T10:06:38+00:00","mainEntityOfPage":{"@id":"https:\/\/elmoustkbal.com\/?p=1176"},"wordCount":912,"articleSection":["COX"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/elmoustkbal.com\/?p=1176","url":"https:\/\/elmoustkbal.com\/?p=1176","name":"\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it is launched, and efforts to determine the most appropriate therapeutic window, perhaps guided by non-invasive biomarkers to assess DAMP-mediated activation of the innate immune system, should be pursued in future studies - DHFR inhibitors in non-small cell lung cancer","isPartOf":{"@id":"https:\/\/elmoustkbal.com\/#website"},"datePublished":"2026-05-19T10:06:38+00:00","author":{"@id":"https:\/\/elmoustkbal.com\/#\/schema\/person\/6ba91697c07f5b1e48a1c50fec2fd4a0"},"breadcrumb":{"@id":"https:\/\/elmoustkbal.com\/?p=1176#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/elmoustkbal.com\/?p=1176"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/elmoustkbal.com\/?p=1176#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/elmoustkbal.com\/"},{"@type":"ListItem","position":2,"name":"\ufeffIn addition , the effectiveness of such immune modulation treatment in DMD will likely depend greatly upon the specific stage of disease at which it is launched, and efforts to determine the most appropriate therapeutic window, perhaps guided by non-invasive biomarkers to assess DAMP-mediated activation of the innate immune system, should be pursued in future studies"}]},{"@type":"WebSite","@id":"https:\/\/elmoustkbal.com\/#website","url":"https:\/\/elmoustkbal.com\/","name":"DHFR inhibitors in non-small cell lung cancer","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/elmoustkbal.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/elmoustkbal.com\/#\/schema\/person\/6ba91697c07f5b1e48a1c50fec2fd4a0","name":"webmaster","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/66fbd3a9ef48c403fd533a73978e5557cc8b799f7e461809e4f768dafe87f404?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/66fbd3a9ef48c403fd533a73978e5557cc8b799f7e461809e4f768dafe87f404?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/66fbd3a9ef48c403fd533a73978e5557cc8b799f7e461809e4f768dafe87f404?s=96&d=mm&r=g","caption":"webmaster"},"sameAs":["http:\/\/elmoustkbal.com"],"url":"https:\/\/elmoustkbal.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=\/wp\/v2\/posts\/1176","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1176"}],"version-history":[{"count":1,"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=\/wp\/v2\/posts\/1176\/revisions"}],"predecessor-version":[{"id":1177,"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=\/wp\/v2\/posts\/1176\/revisions\/1177"}],"wp:attachment":[{"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1176"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1176"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/elmoustkbal.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}